Berlin-Based Blood Analytics Innovator aescolab Secures New Funding to Advance Data-Driven Employee Health

aescolab, a Berlin-based healthtech innovator using AI to deliver personalized health insights and lifestyle advice through blood analytics, has closed a new funding round to accelerate its growth. The investment will support the company increasing its footprint in Germany and expanding to international markets.

The round was led by founding investor KRING, a Copenhagen-based ESG impact fund, reaffirming its belief in aescolab’s scalable, tech-powered approach to prevention and workplace health..

“aescolab represents the kind of mission-driven, data-centric innovation we back,” said Martin Kring, Founder of KRING. “They’ve proven that scalable, tech-based tools can lead to real improvements in human health—exactly the kind of impact ESG capital should support.”

Launched in May 2024, aescolab has already served over 1,000 individuals and is actively partnering with several leading German corporates to integrate blood-based insights into broader employee wellbeing strategies.

Its platform analyzes key blood biomarkers to deliver personalized health reports — giving both companies and individuals clear, actionable recommendations. The company aims to establish itself as a leading health partner for businesses that view wellbeing as a strategic priority—while also empowering individuals to take charge of their own health journey.

“We want to be a trusted partner for forward-thinking companies in Germany and the rest of Europe,” said Stephan Alexander Dreier, CEO of aescolab. “aescolab shows how AI and automation can solve one of the most urgent challenges in the modern workplace: keeping people healthy and performing at their best.” “For HR and corporate health leaders, we offer a new, data-driven way to reduce sick days, boost energy levels, and strengthen employer branding.”“This funding allows us to grow our impact and help more companies and individuals make health measurable, personal, and effective.”

At the heart of aescolab’s mission is the conviction that understanding blood values is the foundation for sustainable health. With a focus on prevention, personalization, and performance, the company is positioning itself as a trusted health partner for forward-thinking employers—and a standout in Europe’s evolving healthtech ecosystem.

With this latest round, aescolab has reached a 7-digit total funding volume.

To support this next growth phase, aescolab welcomes a group of highly respected investors and advisors from across tech, strategy, and health:

  • René Svendsen-Tune (former CEO, CEO GN Store Nord (Jabra), EVP Nokia Networks) as Chairman of the Board
  • Jens Bjørn Andersen (former CEO, DSV) to the Board of Directors
  • Dr. Patrick Simon (former Senior Partner, McKinsey Germany;Global McKinsey Health Institute Leadership Team)
  • Dr. Cyrus Alamouti, experienced healthtech strategist and investor KRING, founding investor and ESG-focused impact fund

“aescolab’s model solves a real and growing need with precision and speed,” said René Svendsen-Tune. “The team, the mission, and the technology are all aligned—and I’m excited to help guide the next chapter as Chairman.”

About aescolab

aescolab is a Berlin-based healthtech company using AI-driven blood analytics to generate personalized health reports for employees and individuals. By helping people and organizations understand and act on blood values, aescolab enables measurable, long-term improvements in wellbeing and performance.

About KRING

Founded in 2010 KRING is a Danish venture building company that has built and invested in more than 30 startups in close collaboration with co-founders and leading corporate partners. Through the SpeedbootingTM innovation model, KRING develops fast-tracked, validated, and scalable business models, and in 2022 launched its largest impact fund to date.

KRING's approach to sustainable venture building is strategically aligned with the EU’s Competitiveness Compass, addressing Europe’s need for resilience, sustainability, and strategic autonomy. The company accelerates cost-effective innovations across key sectors such as digital AI infrastructure, health innovation, energy transformation, and female-founded entrepreneurship to strengthen Europe’s long-term competitiveness.

Media Contact:

press@aescolab.de
www.aescolab.de

Back